A Message from the ESMO President By Ogkologos - March 17, 2020 576 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR 31-Year-Old Woman Diagnosed with Breast Cancer Just 11 Days Before Her... June 21, 2021 ESMO Targeted Anticancer Therapies Congress 2024, 26-28 February, Paris, France February 20, 2024 How could proposed changes to data protection laws affect research? December 8, 2021 Pine Trees or COVID? September 2, 2020 Load more HOT NEWS FDA Approves Lorlatinib for Metastatic ALK-positive Non-Small Cell Lung Cancer Breaking News: Medical Debt and Your Credit Report EMA Recommends Extension of Indications for Trastuzumab Deruxtecan Artist Tattoos Realistic Nipples On Breast Cancer Survivors Post-Mastectomy
